0001214659-19-005669.txt : 20190905
0001214659-19-005669.hdr.sgml : 20190905
20190905164402
ACCESSION NUMBER: 0001214659-19-005669
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190903
FILED AS OF DATE: 20190905
DATE AS OF CHANGE: 20190905
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Amado Rafael
CENTRAL INDEX KEY: 0001662119
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38693
FILM NUMBER: 191077598
MAIL ADDRESS:
STREET 1: 5 ASHWOOD LANE
CITY: MALVERN
STATE: PA
ZIP: 19435
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allogene Therapeutics, Inc.
CENTRAL INDEX KEY: 0001737287
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 823562771
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: (650) 457-2700
MAIL ADDRESS:
STREET 1: 210 EAST GRAND AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-45677.xml
PRIMARY DOCUMENT
X0306
4
2019-09-03
0001737287
Allogene Therapeutics, Inc.
ALLO
0001662119
Amado Rafael
210 EAST GRAND AVE
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
EVP of R&D and CMO
Common Stock
2019-09-03
4
A
false
105162
0.00
A
105162
D
Stock Option (Right to Buy)
26.15
2019-09-03
4
A
false
160630
0.00
A
2029-09-02
Common Stock
160630
160630
D
Twenty-five percent of the shares subject to the stock option shall vest on the first anniversary of the grant date, and the remaining shares shall vest in 36 equal monthly installments thereafter.
Veer Bhavnagri as attorney-in-fact for Rafael Amado
2019-09-05